Podcasts about clinical investigator

Mpox virus (MPXV) is evolving. So is the science. In this presentation, I'll discuss the current mpox vaccine landscape and next-generation vaccines being developed to improve large-scale production and long-term efficacy. If successful, these next-gen vaccines will help the scientific community stay ahead of the curve. ****** Hi, my name is Dr. Amos Ndhere! I am a medical doctor, Clinical Investigator, and Regulatory affairs specialist. My goal is simple: To provide pharmaceutical R&D leaders with clinical trial strategies that optimize outcomes and allow them to access emerging markets. Let's talk: https://www.aceresearchafrica.com/com ****** PS - Join the conversation on social! https://www.linkedin.com/in/amosndhere https://twitter.com/amosndhere https://facebook.com/amosndhere https://www.instagram.com/amos.ndhere/Clinical Research #mpox #vaccine #clinicaltrials #clinicalresearch #publichealth

This week on the Where Parents Talk podcast, host Lianne Castelino speaks to Dr. Rachel Gross, Pediatrician Clinical Research Investigator, Associate Professor of Pediatrics, New York University Grossman School of Medicine, Associate Professor, Department of Population Health, and mother of 2 about long COVID symptoms in kids and teens.

Natasha (Tasha) Hindman, O.D., has been practicing optometry since 2003. She graduated Magna Cum Laude with a B.S. in Biochemistry at Roberts Wesleyan College in Rochester, NY, where she also played basketball, captaining her team. She then attended Pennsylvania College of Optometry (now Salus University) where she received a BS in Visual Science as well as her doctorate (OD). At Scott and Christie Eyecare Associates, Dr. Hindman serves as the Director of Clinical Research for their Eye Research Institute. In this role, she serves effectively to advance the future technology of eyecare through clinical trials with a focus on dry eye, glaucoma, blepharitis, presbyopia, myopia and allergies.

“It was nothing to worry about,” Andrew was repeatedly told, when he visitedurgent care twice for pain in his pelvis area. But the discomfort wouldn't go away, so he met with his primary care physician who referred him to a urologist for an ultrasound. The scans led to a testicular cancer diagnosis in early 2023. It was caught early enough, and he was told there was a good prognosis. The cancer had only spread very lightly to his lymph nodes. Adam works as the director of data analytics for a pharmaceutical company. Heloves vacationing with his family, watching his children play their sports (soccer for his son Jacob and gymnastics for his daughter Julia) and caring for his 2004 BMW. He hopes to help normalize conversations around testicular cancer for other men so they can overcome stigmas and shame around it. Today, he and his wife Kara arecelebrating their wedding anniversary. Dr. Atish Choudhury is a medical oncologist and clinical/translational investigatorwithin the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, and currently serves as Chair of the Gelb Center for Translational Research. He also serves as an Assistant Professor of Medicine at Harvard Medical School. His research interests include investigation of genetic and epigenetic biomarkers from circulating free DNA from patients with metastatic cancer, biomarker studies from other banked human specimens from patients participating in clinical trials, and clinical investigation in novel therapeutics for genitourinary malignancies. According to the American Cancer Society, testicular cancer is not common. About 1 of every 250 males will develop testicular cancer at some point during their lifetime. The American Cancer Society's estimate for testicular cancer in the United States for 2024 is about 9,760 new cases of testicular cancer diagnosed. The average age of males when first diagnosed with testicular cancer is about 33. This is largely a disease of young and middle-aged men, but about 6% of cases occur in children and teens, and about 8% occur in men older than 55.

Featuring perspectives from Dr Jesús G Berdeja and Dr Thomas Martin, including the following topics: Introduction: Real-World Regulatory Issues in Multiple Myeloma (MM) (0:00) Newly Diagnosed MM (14:30) Novel Agents for Relapsed/Refractory MM (24:58) Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies (44:28) CME information and select publications

Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma.

Featuring perspectives from Dr Evan J Lipson, including the following topics: Introduction: Johns Hopkins University (0:00) Metastatic Melanoma (8:21) Nonmetastatic Melanoma and Other Skin Cancers (34:20) CME information and select publications

Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/MM).

Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Skin).

Featuring perspectives from Dr Matthew Gubens, including the following topics: Introduction: Risk of Autoimmune Toxicity with Checkpoint Inhibitors (0:00) Immunotherapy in the Neoadjuvant/Adjuvant Setting (7:33) Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (15:45) First-Line Immunotherapy for Metastatic NSCLC (24:04) Novel Agents and Strategies (30:39) Immunotherapy for NSCLC with a Targetable Mutation (41:34) Small Cell Lung Cancer (47:06) CME information and select publications

Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 datasets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations.

Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 data sets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/NontargetedLung).

Featuring perspectives from Dr Dana M Chase, including the following topics: Introduction: ASCO 2024 Review (0:00) Ovarian Cancer (14:29) HER2 as a Therapeutic Target (29:18) Endometrial Cancer (38:55) Cervical Cancer (51:11) CME information and select publications

Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Gyn).

Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers.

In this episode the incredible Dr Thomas Levy, Board Certified Cardiologist and Attorney, author of 13 books including: Curing the Incurable - the Vitamin C story and it's therapeutic effects The Hidden Epidemic - the story around dental infections, root canals and their affect on cardiovascular disease and breast cancer and beyond. Death by Calcium - the truth about calcium and why supplementing with calcium is a bad idea. Rapid Virus Recovery - all about dealing with viruses successfully  Magnesium: Reversing Disease  Dr Thomas has been on this show twice so make sure you also listen in to those episodes  Curing the Incurable all about IV and oral Vitamin C  (this one has had over 150,000 views/listens.    and Rapid Virus Recovery   In this episode we dive into Dr Thomas's latest learnings and his top 8 (affordable) supplements and why he thinks most people would benefit from these and how they work in the body.   We dive into his research on Methylene Blue and its ability to help those with mitochondrial dysfunction and energy problems.    We also get into why 100% of root canals are infected and the terrible effect that can have on your risks for developing heart disease and also breast cancer.    We dive again into the benefits and many faceted roles that vitamin C plays in the body as not only a powerful antioxidant but how it has the ability to get everywhere in the body and why that makes it much more powerful than many other antioxidants and we discuss it's roles in everything from cancer to covid to sepsis to cardiovascular disease and osteoporosis.   We also discuss his indepth research into why calcium is so detrimental when it is higher in the body than it should be and why just a small increase of calcium in the soft tissues outside of bone and teeth has such deleterious effects and why magnesium is so beneficial and how it counteracts calciums deleterious effects in the body.   We also look into iron and how it promotes cancer and why it can be elevated in people suffering with viruses and pathogens that are chronic. We also discuss copper toxicity and why so many have too much free copper which can be as toxic as mercury.   Antimony is another topic we get into and why it's so high in the population.   Lastly we dive into osteoporosis why it's actually focal scurvy and a lack of vitamin C.   This episode is a masterclass in health optimisation that you will want to repeat over and over again.   To subscribe to Dr Levy's newsletter and to read his articles, get copies of his books etc go to  https://www.tomlevymd.com/   You can also read many of his in depth articles on the Orthomolecular New Service at  https://www.tomlevymd.com/     BIO   Johns Hopkins University, 1968-72—B.A., Biology Tulane University School of Medicine, 1972-76—M.D. University of Denver College of Law, 1995-98—J.D. Post-Graduate Training: Internship and Internal Medicine Residency, 1976-79, Tulane University Affiliated Hospitals Fellowship in Cardiology, 1979-81, Tulane University Affiliated Hospitals LICENSURE AND CERTIFICATION: Federal Licensing Examination (FLEX), 1976 American Board of Internal Medicine, Internal Medicine Board Certification, 1979 Cardiovascular Diseases Subspecialty Board Certification, 1981 Admitted to Colorado Bar, 1998 Admitted to District of Columbia Bar, 1999 PROFESSIONAL ORGANIZATIONS: Advanced Amateur Radio Operator, 1974—present [WB5CTC] American College of Physicians (ACP), Member, 1980—2002 Louisiana State Medical Society, 1976-91 American College of Cardiology (ACC), Fellow, 1983—present American Society of Clinical Hypnosis (ASCH), Member, 1990-2000 El Paso County Medical Society (Colorado), 1991-1995 American Inn of Court, Judge William E. Doyle Inn, Pupil, 1997-8; Associate Barrister, 1999 to present Colorado Bar Association, 1998-2002 El Paso County Bar Association, 1999 American College of Forensic Examiners (ABFM), Member, 1999 American College of Forensic Examiners (ABFM), Diplomate, 1999 Induction into the Orthomolecular Medicine Hall of Fame, April 2016 PROFESSIONAL POSITIONS AND HOSPITAL AFFILIATIONS: Supervisor, Major Medical Emergency, Charity Hospital of New Orleans, 1980-83 Assistant Professor of Medicine, Tulane Medical School, 1981-83 Clinical Investigator, DDD Pacemaker, entitled "Clinical Study for Telectronics Model 2251, Dual Chamber Pulse Generator" Member, Formulary Review—Cardiovascular Section, Charity Hospital of New Orleans, 1981-83 Instructor in Radiology, Tulane Medical School, 1983-4 Clinical Assistant Professor of Medicine, Tulane Medical School, 1983-1986 Staff, Iberia General Hospital, New Iberia, Louisiana, 1984-91 Staff, Memorial Hospital, Colorado Springs, Colorado, 1991-present Staff, Denver General Hospital, Denver, Colorado, 1995-6 Medical Technical Advisor, International Tesla Society, Colorado Springs, Colorado, 1994-8 PUBLICATIONS Graybar, G., Goethe, J., Levy, T., Phillips, J., Youngberg, J., and Smith, D., "Transient Large Upright T-Wave During Multiple Monitored Electroconvulsive Therapy," Anesthesiology, 59(5):467-469 (1983). Levy, T., Trauma Rounds "Problem: Cardiac Contusion," Annals of Emergency Medicine, July 15, 1983. Levy, T. and Huggins, H., "Routine Dental Extractions Routinely Produce Cavitations," Journal of Advancement in Medicine, 9(4):235-249 (1996) Huggins, H. and Levy, T., "Cerebrospinal Fluid Protein Changes in Multiple Sclerosis After Dental Amalgam Removal," Alternative Medicine Review, 3(4):295-300 (1998) Huggins, H. and Levy, T., Uninformed Consent: The Hidden Dangers in Dental Care, Charlottesville, VA: Hampton Roads Publishing Company, Inc.; 1999 Levy, T., Optimal Nutrition for Optimal Health: The Real Truth About Eating Right for Weight Loss, Detoxification, Low Cholesterol, Better Digestion, and Overall Well-Being, New York, NY: McGraw-Hill (Keats Publishing); 2001 Kulacz, R. and Levy, T., The Roots of Disease: Connecting Dentistry and Medicine, Philadelphia, PA: Xlibris Corporation; 2002 Levy, T., Curing the Incurable: Vitamin C, Infectious Diseases, and Toxins, Henderson, NV: Medfox Publishing; 2002 Levy, T., Stop America's #1 Killer! Reversible Vitamin Deficiency Found to be Original of ALL Coronary Heart Disease, Henderson, NV: Medfox Publishing; 2006 Levy, T., GSH: Master Defender Against Disease, Toxins, and Aging, Henderson, NV: Medfox Publishing; 2008 Levy, T., Living in Your Right Mind, Henderson, NV: Medfox Publishing; 2010 Levy, T., Primal Panacea, Henderson, NV: MedFox Publishing; 2011 Levy, T., Death by Calcium, Henderson, NV: MedFox Publishing; 2013 Kulacz, R. and Levy, T., The Toxic Tooth, Henderson, NV: MedFox Publishing; 2014 Levy, T., Hidden Epidemic, Henderson, NV: MedFox Publishing; 2017 Levy, T., Magnesium: Reversing Disease, Henderson, NV: MedFox Publishing; 2019 Levy, T., Rapid Virus Recovery: No need to live in fear!, Henderson, NV: MedFox Publishing; 2021   Personalised Health Optimisation Consulting with Lisa Tamati Lisa offers solution focused coaching sessions to help you find the right answers to your challenges. Topics Lisa can help with:  Lisa is a Genetics Practitioner, Health Optimisation Coach, High Performance and Mindset Coach. She is a qualified Ph360 Epigenetics coach and a clinician with The DNA Company and has done years of research into brain rehabilitation, neurodegenerative diseases and biohacking. She has extensive knowledge on such therapies as hyperbaric oxygen,  intravenous vitamin C, sports performance, functional genomics, Thyroid, Hormones, Cancer and much more. She can assist with all functional medicine testing. Testing Options Comprehensive Thyroid testing DUTCH Hormone testing Adrenal Testing Organic Acid Testing Microbiome Testing Cell Blueprint Testing Epigenetics Testing DNA testing Basic Blood Test analysis Heavy Metals  Nutristat Omega 3 to 6 status and more  Lisa and her functional medicine colleagues in the practice can help you navigate the confusing world of health and medicine . She can also advise on the latest research and where to get help if mainstream medicine hasn't got the answers you are searching for whatever the  challenge you are facing from cancer to gut issues, from depression and anxiety, weight loss issues, from head injuries to burn out to hormone optimisation to the latest in longevity science. Book your consultation with Lisa    Join our Patron program and support the show Pushing the Limits' has been free to air for over 8 years. Providing leading edge information to anyone who needs it. But we need help on our mission.  Please join our patron community and get exclusive member benefits (more to roll out later this year) and support this educational platform for the price of a coffee or two You can join by going to  Lisa's Patron Community Or if you just want to support Lisa with a "coffee" go to  https://www.buymeacoffee.com/LisaT to donate $3   Lisa's Anti-Aging and Longevity Supplements  Lisa has spent years curating a very specialized range of exclusive longevity, health optimizing supplements from leading scientists, researchers and companies all around the world.  This is an unprecedented collection. The stuff Lisa wanted for her family but couldn't get in NZ that's what it's in her range. Lisa is constantly researching and interviewing the top scientists and researchers in the world to get you the best cutting edge supplements to optimize your life.   Subscribe to our popular Youtube channel  with over 600 videos, millions of views, a number of full length documentaries, and much more. You don't want to miss out on all the great content on our Lisa's youtube channel. Youtube   Order Lisa's Books Lisa has published 5 books: Running Hot, Running to Extremes, Relentless, What your oncologist isn't telling you and her latest "Thriving on the Edge"  Check them all out at  https://shop.lisatamati.com/collections/books   Perfect Amino Supplement by Dr David Minkoff Introducing PerfectAmino PerfectAmino is an amino acid supplement that is 99% utilized by the body to make protein. PerfectAmino is 3-6x the protein of other sources with almost no calories. 100% vegan and non-GMO. The coated PerfectAmino tablets are a slightly different shape and have a natural, non-GMO, certified organic vegan coating on them so they will glide down your throat easily. Fully absorbed within 20-30 minutes! No other form of protein comes close to PerfectAminos Listen to the episode with Dr Minkoff here:    Use code "tamati" at checkout to get a 10% discount on any of their devices.   Red Light Therapy: Lisa is a huge fan of Red Light Therapy and runs a Hyperbaric and Red Light Therapy clinic. If you are wanting to get the best products try Flexbeam: A wearable Red Light Device https://recharge.health/product/flexbeam-aff/?ref=A9svb6YLz79r38   Or Try Vielights' advanced Photobiomodulation Devices Vielight brain photobiomodulation devices combine electrical engineering and neuroscience. To find out more about photobiomodulation, current studies underway and already completed and for the devices mentioned in this video go to www.vielight.com and use code “tamati” to get 10% off     Enjoyed This Podcast? If you did, subscribe and share it with your friends! If you enjoyed tuning in, then leave us a review and share this with your family and friends. Have any questions? You can contact my team through email (support@lisatamati.com) or find me on Facebook, Twitter, Instagram and YouTube. For more episode updates, visit my website. You may also tune in on Apple Podcasts.  To pushing the limits, Lisa and team

Featuring perspectives from Dr Aaron T Gerds, including the following topics: Introduction: Myelofibrosis (MF) for Oncology “Newbies” (0:00) Biology of MF (5:20) Management of Anemia in MF (20:12) Novel Strategies for MF (29:28) Journal Club (46:12) CME information and select publications

Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis.

Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/MF).

Featuring perspectives from Dr Justin F Gainor and Dr Karen Reckamp, including the following topics: Introduction: Bringing Research into Practice (0:00) EGFR Activating Mutations (14:01) Exon 20 Insertion Mutations (38:06) MET Exon 14 Alterations (41:49) HER2 Mutations and Overexpression (50:27) CME information and select publications

Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets.

Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/TargetedLung).

Our bodies change as we age, and the condition of overactive bladder can interfere with sleep patterns and quality of life. This week on the show, Dr. Quave speaks with Dr. Ted Johnson, who works in geriatric medicine, which is a medical specialty dedicated exclusively to providing high-quality, patient-centered care for older adults. Ted has over 25 years of clinical practice and is Chief of Emory General Internal Medicine, Chair of Emory Family and Preventive Medicine, and a Clinical Investigator at the Atlanta VA Healthcare System. He elaborates on causes, symptoms, and treatments including behavior changes, exercises, and the impact of diet. Learn the science behind urgency, urinary frequency, and nocturia, and explore how factors like caffeine and body mass index play a role. This episode promises insights not only for medical professionals but also for anyone looking to understand and manage bladder health better.   #bladderhealth #diet #overactivebladder #sleep

Featuring perspectives from Dr Naval Daver and Dr Courtney D DiNardo, including the following topics: Introduction (0:00) Available and Emerging Nontargeted Therapies for Acute Myeloid Leukemia (AML) —Dr Daver (6:47) Current and Emerging Role of Biomarker-Directed Therapeutic Approaches for Patients with AML —Dr DiNardo (32:58) CME information and select publications

Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease.

Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/AML).

When the search for truth leads us through a labyrinth of facts and fiction, it's the keen eyes of people like Erik Avanier, a seasoned reporter from WJXT News Channel 4, who light the way. Our latest MedEvidence conversation is anything but ordinary, as Dr. Michael Koren, flips the script to uncover the story behind the storyteller. Erik, with a background influenced by his godmother's legacy at Jet Magazine, shares his passage from the world of print to the dynamic arena of television reporting. His insights into localizing national stories are invaluable, particularly our joint ventures during the pandemic that brought crucial, community-specific information to the forefront.Join us as we share the lessons learned from the front lines of media to how we find the facts in medicine through clinical trials as both investigators looking for the truth.Recording Date: April 19, 2024Be a part of advancing science by participating in clinical researchShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com Powered by ENCORE Research GroupMusic: Storyblocks - Corporate InspiredThank you for listening!

Featuring perspectives from Prof Thierry André and Dr Arvind Dasari, including the following topics: Introduction: Year in Review on the Ground (0:00) Treatment of HER2-Positive Colorectal Cancer (CRC) (7:50) Immune Checkpoint Inhibitors for Microsatellite Instability-High CRC (24:12) Other Key Issues (45:30) Questions and Cases from the Community (52:30) CME information and select publications

Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.

Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.

Featuring perspectives from Dr Shilpa Gupta and Prof Thomas Powles, including the following topics: Introduction: The Cancer-Immunity Cycle (0:00) Nonmetastatic Urothelial Bladder Cancer — Dr Gupta (7:30) Metastatic Urothelial Bladder Cancer — Prof Powles (33:06) CME information and select publications

Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Bladder).

Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/CRC).

Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.

Featuring perspectives from Dr Andrew J Armstrong and Dr Maha Hussain, including the following topics:  Introduction: Carpool Karaoke — RTP Style (0:00) Hormonal Therapy (13:36) Other Treatment Approaches (36:50) CME information and select publications   

Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer.

Featuring perspectives from Dr Andrew M Evens and Dr Sonali M Smith, including the following topics:  Introduction: CD3-Based Bispecific Antibodies and the General Medical Oncologist: Lymphomas, Multiple Myeloma … and Solid Tumors? (0:00) Follicular and Mantle Cell Lymphoma (7:17) Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma (30:10) CME information and select publications   

Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Prostate).

Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma.

Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Lymphoma).

Featuring perspectives from Dr Ian E Krop and Dr Priyanka Sharma, including the following topics:  Introduction: Educating Non-Breast Cancer Specialty Oncologists About HER2-Targeted Therapies – ASCO Genitourinary Cancers Symposium 2024 (0:00) HER2-Positive Breast Cancer — Dr Krop (12:30) Triple-Negative Breast Cancer — Dr Sharma (36:34) CME information and select publications   

Dr Ian E Krop from the Yale Cancer Center in New Haven, Connecticut, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss patient cases and treatment strategies for HER2-positive and triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/HER2PosTNBC).

Dr Ian E Krop from the Yale Cancer Center in New Haven, Connecticut, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss patient cases and treatment strategies for HER2-positive and triple-negative breast cancer.

Featuring perspectives from Dr Yelena Y Janjigian and Dr Zev Wainberg, including the following topics: Introduction: First-Line Therapy for Metastatic Gastroesophageal (GE) Cancers — the Bottom Line (0:00) Updates on Immunotherapy in GE Cancers (18:51) Targeting HER2 (33:11) Targeting Claudin 18.2 — Zolbetuximab (54:42) CME information and select publications

Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Gastroesophageal).

Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman, including the following topics: An Audio Depiction of Mechanisms of Action of Bcl-2 Inhibitors, Anti-CD20 Antibodies and Covalent and Noncovalent Bruton Tyrosine Kinase Inhibitors; Mechanisms of Resistance (0:00) Current Management Approaches for Patients with Chronic Lymphocytic Leukemia (CLL) — Dr Sharman (12:27) Future Directions in the Care of Patients with CLL — Dr Roeker (33:54) CME information and select publications  

Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia.

Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/CLL).

Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer, including the following topics: Introduction: Endocrinology and Pharmacology of Hormonal Therapy for Breast Cancer (0:00) Current and Emerging Strategies for Localized Hormone Receptor (HR)-Positive Breast Cancer — Dr Graff (17:02) Advances in the Care of Patients with HR-Positive Metastatic Breast Cancer — Dr Mayer (38:59) CME information and select publications

Dr Stephanie L Graff from the Legorreta Cancer Center at Brown University in Providence, Rhode Island, and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston discuss treatment decision-making involving approved and investigational strategies for the management of hormone receptor-positive breast cancer. CME information and select publications here (https://www.researchtopractice.com/YiR2023/HRPosBC).